Paradoxical Changes in Muscle Gene Expression in Insulin-Resistant Subjects After Sustained Reduction in Plasma Free Fatty Acid Concentration
Paradoxical Changes in Muscle Gene Expression in Insulin-Resistant Subjects After Sustained Reduction in Plasma Free Fatty Acid Concentration Mandeep Bajaj 1 2 , Rafael Medina-Navarro 3 , Swangjit Suraamornkul 2 , Christian Meyer 2 4 , Ralph A. DeFronzo 2 and Lawrence J. Mandarino 3 1 University of...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 56; no. 3; pp. 743 - 752 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.03.2007
|
Subjects | |
Online Access | Get full text |
ISSN | 0012-1797 1939-327X |
DOI | 10.2337/db06-0840 |
Cover
Summary: | Paradoxical Changes in Muscle Gene Expression in Insulin-Resistant Subjects After Sustained Reduction in Plasma Free Fatty
Acid Concentration
Mandeep Bajaj 1 2 ,
Rafael Medina-Navarro 3 ,
Swangjit Suraamornkul 2 ,
Christian Meyer 2 4 ,
Ralph A. DeFronzo 2 and
Lawrence J. Mandarino 3
1 University of Texas Medical Branch, Galveston, Texas
2 University of Texas Health Science Center, San Antonio, Texas
3 Center for Metabolic Biology, Arizona State University, Tempe, Arizona
4 Carl T. Hayden VA Medical Center, Phoenix, Arizona
Address correspondence and reprint requests to Lawrence J. Mandarino, PhD, Director, Center for Metabolic Biology, Professor
and Chair, Department of Kinesiology, Professor, School of Life Sciences, Arizona State University, P.O. Box 874501, Tempe,
AZ 85287-4501. E-mail: lawrence.mandarino{at}asu.edu
Abstract
Lipid oversupply plays a role in developing insulin resistance in skeletal muscle, decreasing expression of nuclear-encoded
mitochondrial genes, and increasing extracellular matrix remodeling. To determine if a decrease in plasma lipid content reverses
these abnormalities, insulin-resistant subjects with a family history of type 2 diabetes had euglycemic clamps and muscle
biopsies before and after acipimox treatment to suppress free fatty acids. Free fatty acids fell from 0.584 ± 0.041 to 0.252
± 0.053 mmol/l ( P < 0.001) and glucose disposal increased from 5.28 ± 0.46 to 6.31 ± 0.55 mg · kg −1 · min −1 ( P < 0.05) after acipimox; intramuscular fatty acyl CoA decreased from 10.3 ± 1.9 to 4.54 ± 0.82 pmol/mg muscle ( P < 0.01). Paradoxically, expression of PGC-1–and nuclear-encoded mitochondrial genes decreased after acipimox, and expression
of collagens I and III α-subunits (82- and 21-fold increase, respectively, P < 0.05), connective tissue growth factor (2.5-fold increase, P < 0.001), and transforming growth factor-β1 increased (2.95-fold increase, P < 0.05). Therefore, a reduction in lipid supply does not completely reverse the molecular changes associated with lipid oversupply
in muscle. Changes in expression of nuclear-encoded mitochondrial genes do not always correlate with changes in insulin sensitivity.
CTGF, connective tissue growth factor
FFA, free fatty acid
OGTT, oral glucose tolerance test
TGF, transforming growth factor
Footnotes
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore
be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Accepted December 18, 2006.
Received June 20, 2006.
DIABETES |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/db06-0840 |